Casale Donn
Reporting owner on Forms 3, 4 and 5, CIK 2135296.
Casale Donn reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ARS Pharmaceuticals, Inc. CIK 1671858 | director, officer (President and CEO) | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. Stock Option (right to buy), derivative | 2026-10-01 | A granted | +1,036,923 | $0 | 1,036,923 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002135296-26-000009 | ARS Pharmaceuticals, Inc. | 2026-10-05 |